Video

Effective Adherence Management for Specialty Pharmacy

Author(s):

Lauren Santye, Assistant Editor

Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses effective measures for maintaining adherence to specialty drug regimens.

Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses effective measures for maintaining adherence to specialty drug regimens.

Related Videos
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
Patient receiving diabetes consultation -- Image credit: Syda Productions | stock.adobe.com
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Related Content
Woman holding images of kidneys -- Image credit: SewcreamStudio | stock.adobe.com
February 4th 2025

Prevalence of CKD in Patients With LN and SLE Ranges From 10% to Almost 50%, Review Finds

Gillian McGovern, Associate Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Advances in Dermatomyositis Treatment
January 31st 2025

Patients With Juvenile Dermatomyositis Treated With IVIG Had No Increased Risk of Thromboembolic Events

Luke Halpern, Assistant Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

The designation is based on preliminary clinical data from the phase 2 DAWN (NCT06275620) and SKYLINE (NCT06333249) trials.| Image Credit: blackday | stock.adobe.com
January 31st 2025

FDA Grants Regenerative Medicine Advanced Therapy Designation to Laru-Zova for X-Linked Retinitis Pigmentosa

Ashley Gallagher, Editor
Pharmacists educate and counsel patients on effective use of GLP-1 medication. | Image Credit: K KStock | stock.adobe.com
January 31st 2025

Q&A: Pharmacists Play Pivotal Role in Evolving Diabetes Care with New Treatments

Ashley Gallagher, Editor